Business Development & Licensing
Forecasts drive deals
What We Do
We empower BD&L teams with clarity and confidence to make decisions at the pace and stakes of deal-making. Viscadia supports business development and licensing teams across every phase of the deal cycle, from landscape evaluation to transaction-ready decision support. Our work is built for live deal environments: fast, rigorous, and tailored to where you are in the process.
BD Roadmap
Translating Portfolio Needs and Strategic Imperatives into a blueprint delivering clear direction on where, and how, to identify the right assets to meet your needs.
Therapeutic Area Prioritization
Assess therapy areas using competitive intensity, commercial potential, and strategic fit to identify priority areas for investment.
Asset Search, Screening, & Prioritization
Identify and screen marketed and pipeline assets against defined criteria, using multi-dimensional scoring aligned to your mandate to surface the highest potential opportunities.
Commercial Opportunity Assessment
Evaluate the commercial viability of an asset by assessing market opportunity, competitive positioning, and potential to deliver sustainable value.
Deal Modeling
Design deal structures and financial outcomes, translating asset potential into clear views on value, returns, and risk to support informed deal decisions.
Post-Deal Support
Facilitate execution and value realization post-deal through ongoing forecasting, market analysis, and lifecycle planning.
0+
Assets evaluated across pipeline and marketed products.
0–0
Weeks From shortlist to decision-ready assessment.
0MM-0BN+
Deal value supported through Viscadia engagements.
Built for the Phase You’re In
Every BD&L engagement is different. Some clients partner with us proactively to identify and prioritize opportunities, while others come with a specific asset or shortlist and require focused evaluation. Wherever the decision sits, our work meets it there.
Mapping opportunities before assets are evaluated in depth.
We scan assets, therapeutic areas, and competitive dynamics against a client-aligned mandate to produce TA heatmaps and a prioritized shortlist. This evaluation is built for teams navigating a broad target landscape by helping focus efforts on the most promising candidates.
Evaluating commercial potential with decision-grade rigor.
Commercial potential is evaluated through analysis of market landscape, unmet need, competitive positioning, pricing and access dynamics, and expected adoption. Robust forecasts are developed for marketed and pipeline assets to support strategic planning and investment decisions.
Modeling the financials and deal terms behind the decision.
Deal structures are modeled across clinical development phases, incorporating upfront payments, milestones, royalties, and cash flow outcomes to assess financial impact under multiple scenarios. NPV and risk-adjusted NPV analyses support rigorous go/no-go decisions ahead of deal execution.
Strategy and Portfolio Optimization
Patient-level forecasting for Four drugs with 1B+ in total revenue.
Case Studies
Pipeline Forecast
Global model for oncology condition with a complex patient flow, where the client gained unprecedented buy-in from 15 regional counterparts and global HQ.
Case Studies
On-Market Product Forecast
Forecasting with higher accuracy and greater versatility in a competitive market.
Engage with Us
At Viscadia, we are dedicated to excellence in everything we do. Discover how our specialized focus can support your professional growth or drive your company’s success.
